Гипотиреоз Кодирование по Международной статистической классификации болезней и проблем, связанных со здоровьем: Е03. 1

22 
9.
Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical 
hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab
2012 Jun;97(6):1962-9. doi: 10.1210/jc.2011-3047. 
10.
Surks M. I. et al. Subclinical thyroid disease: scientific review and guidelines for 
diagnosis and management //Jama. – 2004. – Т. 291. – №. 2. – С. 228-238. 
11.
Meyerovitch J, Rotman-Pikielny P, Sherf M, Battat E, Levy Y, Surks MI. Serum 
thyrotropin measurements in the community: five-year follow-up in a large network of 
primary care physicians. Arch Intern Med. 2007 Jul 23;167(14):1533-8. doi: 
10.1001/archinte.167.14.1533. 
12.
Neumann S., Raaka B.M., Gershengorn M.C. Constitutively active thyrotropin and 
thyrotropin-releasing hormone receptors and their inverse agonists. Methods Enzymol. 
2010; N.485: с. 147-160. 
13.
Barbesino G, Sluss PM, Caturegli P: Central hypothyroidism in a patient with pituitary 
autoimmunity: evidence for TSH-independent thyroid hormone synthesis. J Clin 
Endocrinol Metab 2012; 97: 345–350. 
14.
Persani L. Clinical review: central hypothyroidism: pathogenic, diagnostic, and 
therapeutic challenges. J Clin Endocrinol Metab 2012; N. 97: с. 3068–3078. 
15.
Alexopoulou O,Beguin C, De Nayer P, Maiter D. Clinical and hormonal characteristics 
of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J 
Endocrinol. 2004 Jan;150(1):1-8. doi: 10.1530/eje.0.1500001.
16.
Persani L, Cangiano B, Bonomi M. The diagnosis and management of central 
hypothyroidism in 2018. Endocr Connect. 2019 Feb;8(2):R44-R54. doi: 10.1530/EC-18-
0515. 
17.
Grunenwald S., Caron P. Central hypothyroidism in adults: better understanding for 
better care. Pituitary. 2015; N. 18(1): с. 169-175.
18.
Constine L.S., Woolf P.D., Cann D., Mick G., McCormick K., Raubertas R.F., Rubin P. 
Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993; 
N. 328(2): с. 87-94.
19.
Snyder P.J., Fowble B.F., Schatz N.J., Savino P.J., Gennarelli T.A. Hypopituitarism 
following radiation therapy of pituitary adenomas. Am J Med. 1986; N. 81(3): с. 457-
462. 
20.
Fernandez-Rodriguez E., Bernabeu I., Castro A.I., Casanueva F.F. Hypopituitarism after 
traumatic brain injury. Endocrinol Metab Clin North Am. 2015; N.44(1): с. 151-159.
21.
Krewer C., Schneider M., Schneider H.J., Kreitschmann-Andermahr I., Buchfelder M., 
Faust M., Berg C., Wallaschofski H., Renner C., Uhl E., Koenig E., Jordan M., Stalla 

23 
G.K., Kopczak A.. Neuroendocrine disturbances one to five or more years after traumatic 
brain injury and aneurysmal subarachnoid hemorrhage: data from the German database 
on hypopituitarism. J Neurotrauma. 2016; N. 33(16): с. 1544-1553.
22.
Brent G.A. Mechanisms of thyroid hormone action. J Clin Invest. 2012; N. 122(9): с. 
3035-3043.
23.
Dow K.H., Ferrell B.R., Anello C. Quality-of-life changes in patients with thyroid cancer 
after withdrawal of thyroid hormone therapy. Thyroid. 1997; N.7(4): с. 613-619. 
24.
Mandel SJ, Brent GA, Larsen PR Levothyroxine therapy in patients with thyroid disease. 
Ann Intern Med. 1993; N. 119(6): с. 492-502.
25.
Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F. Delayed intestinal 
absorption 
of 
levothyroxine. 
Thyroid. 
1995 
Aug;5(4):249-53. 
doi: 
10.1089/thy.1995.5.249. 
26.
Perez CL, Araki FS, Graf H, de Carvalho GA. Serum thyrotropin levels following 
levothyroxine administration at breakfast. Thyroid. 2013 Jul;23(7):779-84. doi: 
10.1089/thy.2012.0435. 
27.
Singh N, Singh PN, Hershman JM Effect of calcium carbonate on the absorption of 
levothyroxine.JAMA. 2000 Jun 7;283(21):2822-5. doi: 10.1001/jama.283.21.2822.
28.
Ross D.S. Serum thyroid-stimulating hormone measurement for assessment of thyroid 
function and disease. Endocrinol Metab Clin North Am. 2001; N. 30(2): с. 245-264. 
29.
Wenzel K.W., Kirschsieper H.E. Aspects of the absorption of oral L-thyroxine in normal 
man. Metabolism. 1977 Jan;26(1):1-8. doi: 10.1016/0026-0495(77)90121-4.
30.
Woeber K.A. Levothyroxine therapy and serum free thyroxine and free triiodothyronine 
concentrations. J Endocrinol Invest. 2002; Vol. 25(2): с. 106-109. 
31.
Benvenga S., Bartolone L., Pappalardo M.A., Russo A., Lapa D., Giorgianni G., 
Saraceno G., Trimarchi F. Altered intestinal absorption of L-thyroxine caused by coffee. 
Thyroid. 2008; N.18(3): с. 293-301. 
32.
Liel Y., Harman-Boehm I., Shany S. Evidence for a clinically important adverse effect of 
fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J 
Clin Endocrinol Metab. 1996; N.81(2): с. 857-859. 
33.
Perez C.L., Araki F.S., Graf H., de Carvalho G.A. Serum thyrotropin levels following 
levothyroxine administration at breakfast. Thyroid. 2013; N. 23: с. 779-784. 
34.
Zamfirescu I, Carlson HE Absorption of levothyroxine when coadministered with 
various 
calcium 
formulations. 
Thyroid. 
2011 
May;21(5):483-6. 
doi: 
10.1089/thy.2010.0296. . 

24 
35.
Shakir KM, Chute JP, Aprill BS, Lazarus AA Ferrous sulfate-induced increase in 
requirement for thyroxine in a patient with primary hypothyroidism. South Med J. 1997 
Jun;90(6):637-9. doi: 10.1097/00007611-199706000-00011.
36.
Mayor G.H., Orlando T., Kurtz N.M. Limitations of Levothyroxine Bioequivalence 
Evaluation: Analysis of An Attempted Study. American journal of therapeutics Am J 
Ther. 1995; N. 2(6): с. 417-432. 
37.
Eisenberg M., Distefano J.J. TSH-based protocol, tablet instability, and absorption effects 
on L-T4 bioequivalence. Thyroid 2009; N. 19(2): c. 103-110. 
38.
Biondi B., Palmieri .EA., Lombardi G., Fazio S. Effects of subclinical thyroid 
dysfunction on the heart // Ann. Intern. Med. 2002. V. 137 P. 904–914. 
39.
Paul T.L., Kerrigan J., Kelly A.M. et al. Long-term thyroxine therapy is associated with 
decreased hip bone density in premenopausal women // JAMA. 1988. V. 259. P. 3137–
3141. 
40.
Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A 2005 The starting 
dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, 
double-blind trial. Archives of internal medicine 165:1714-1720. 
41.
He Q, Heo M, Heshka S, Wang J, Pierson RN, Jr., Albu J, Wang Z, Heymsfield SB, 
Gallagher D 2003 Total body potassium differs by sex and race across the adult age span. 
The American journal of clinical nutrition 78:72-77. 
42.
Taylor PN, Minassian C, Rehman A et al. 2014 TSH levels and risk of miscarriage in 
women on longterm levothyroxine: a community-based study. J Clin Endocrinol Metab 
99:3895–3902. 
43.
Alexander EK, Marqusee E, Lawrence J et al. 2004 Timing and magnitude of increases in 
levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J 
Med 351:241–249. 
44.
Yassa L, Marqusee E, Fawcett R, Alexander EK 2010 Thyroid hormone early adjustment 
in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab 95:3234–3241. 
45.
Galofre JC, Haber RS, Mitchell AA, et al. 2010 Increased postpartum thyroxine 
replacement in Hashimoto’s thyroiditis. Thyroid 20:901–908. 
46.
Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F. Effects 
of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune 
thyroid disease. Eur J Endocrinol. 2017 Feb;176(2):253-265. doi: 10.1530/EJE-16-0548. .
47.
Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi 
F. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, 

25 
Negative for Thyroid Peroxidase Antibodies. J Clin Endocrinol Metab. 2018 Mar 
1;103(3):926-935. doi: 10.1210/jc.2017-01850. 
48.
Slawik M, Klawitter B, Meiser E et al. Thyroid hormone replacement for central 
hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) 
with a combination of T4 and triiodothyronine. J Clin Endocrinol Metab 2007; 92: 4115–
4122. 
49.
Koulouri O, Auldin MA, Agarwal R et al. Diagnosis and treatment of hypothyroidism in 
TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of 
under-replacement with levothyroxine. Clin Endocrinol 2011; 74: 744–749. 
50.
Persani L, Brabant G, Dattani M, et al. European Thyroid Association (ETA) Guidelines 
on the Diagnosis and Management of Central Hypothyroidism. Eur Thyroid J 2018 
Oct;7(5):225-237. doi: 10.1159/000491388. Epub 2018 Jul 19. 
51.
Leger J, Olivieri A, Donaldson M et al. European Society for Paediatric Endocrinology 
consensus guidelines on screening, diagnosis, and management of congenital 
hypothyroidism. Horm Res Paediatr 2014; 81: 80–103. 
52.
Agha A, Walker D, Perry L, et al. Unmasking of central hypothyroidism following 
growth hormone replacement in adult hypopituitary patients. Clin Endocrinol (Oxf). 
2007;66(1):72-77. doi: http://doi.org/10.1111/j.1365-2265.2006.02688.x. 
53.
Campbell N. R. C. et al. Ferrous sulfate reduces thyroxine efficacy in patients with 
hypothyroidism //Annals of Internal Medicine. – 1992. – Т. 117. – №. 12. – С. 1010-
1013. 
54.
Persani L., Cangiano B., Bonomi M. The diagnosis and management of central 
hypothyroidism in 2018 //Endocrine connections. – 2019. – Т. 8. – №. 2. – С. R44-R54. 
55.
Raber W. et al. Thyroid ultrasound versus antithyroid peroxidase antibody determination: 
a cohort study of four hundred fifty-one subjects //Thyroid. – 2002. – Т. 12. – №. 8. – С. 
725-731. 

жүктеу/скачать 0,96 Mb.

Достарыңызбен бөлісу: